Skip to main content
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: Hepatology. 2021 Jul 26;74(5):2436–2451. doi: 10.1002/hep.31994

Fig. 4. The expression levels of the selected miRNAs and their targets in the liver of patients with AH.

Fig. 4

(A) The selected miRs levels in control and AH liver samples from published RNA-seq dataset (GSE59492). (B–C) The representing western blot images and quantifications of selected targets using 5 samples in each group. (D) The representing IHC images and quantification of CCND2, RRM2 and CCND1. Scale bar: 300μm. *p<0.05; **p<0.01; ***p <0.001; ****p <0.0001 vs HC.